HUB Investment Partners’s AstraZeneca AZN Stock Holding History

HUB Investment Partners’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.2M	Buy	72,008 +7,690	+12%	+$1.48M	0.34%	58
2025 Q4	$11.8M	Buy	+64,318	New	+$11.3M	0.31%	69
2025 Q3	–	Sell	-55,906	Closed	-$7.81M	–	849
2025 Q2	$7.81M	Buy	55,906 +4,543	+9%	+$637K	0.26%	84
2025 Q1	$7.55M	Buy	51,363 +4,343	+9%	+$628K	0.3%	84
2024 Q4	$6.16M	Buy	47,020 +3,917	+9%	+$548K	0.26%	98
2024 Q3	$6.72M	Buy	43,103 +4,383	+11%	+$708K	0.29%	91
2024 Q2	$6.04M	Buy	38,720 +7,119	+23%	+$1.07M	0.23%	96
2024 Q1	$4.28M	Buy	31,601 +6,119	+24%	+$810K	0.23%	109
2023 Q4	$3.43M	Buy	25,482 +6,055	+31%	+$787K	0.23%	108
2023 Q3	$2.63M	Buy	19,427 +2,092	+12%	+$286K	0.4%	66
2023 Q2	$2.48M	Buy	17,335 +1,617	+10%	+$238K	0.41%	66
2023 Q1	$2.18M	Buy	15,718 +2,192	+16%	+$295K	0.45%	64
2022 Q4	$1.83M	Buy	+13,526	New	+$1.7M	0.4%	45

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

HUB Investment Partners's AZN Position: Q1 2026 in Review

HUB Investment Partners increased its AstraZeneca (AZN) stake by 12% in Q1 2026, buying an estimated $1.48M and bringing the position to 72,008 shares worth $14.2M. The position accounts for 0.34% of the portfolio, ranked #58.

HUB Investment Partners first reported a position in AZN in Q4 2022 and has held it in 13 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

HUB Investment Partners held 72,008 shares of AstraZeneca worth $14.2M as of Q1 2026.
HUB Investment Partners bought 7,690 AstraZeneca shares in Q1 2026, an estimated $1.48M.
AstraZeneca made up 0.34% of HUB Investment Partners's portfolio in Q1 2026, its #58 holding.
HUB Investment Partners first reported a position in AstraZeneca in Q4 2022 and has held it in 13 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on HUB Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.